Used as a key intermediate in the synthesis of biologically active compounds, particularly in pharmaceutical development. Its protected piperazine structure allows selective modification, making it valuable in creating drug candidates targeting central nervous system disorders, metabolic diseases, and oncology. Commonly employed in medicinal chemistry for building blocks in protease inhibitors and receptor agonists/antagonists. The Boc group enables controlled deprotection during multi-step syntheses, ensuring high yield and purity in final active pharmaceutical ingredients.